This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Marijuana ETF Enters Bear Territory: What Lies Ahead?
by Sweta Killa
Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.
Marijuana Stocks Plummet to Record Low: What's Next?
by Zacks Equity Research
Legalization has long been considered a boon for the marijuana industry.
The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG
Canada Legalizes Marijuana: Stocks & ETF in Focus
by Neena Mishra
Canada legalized recreational pot today but it's "sell the news" event for pot stocks that have seen astronomical gains recently.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Tilary Buys Alef Biotechnology to Build Base in Latin America
by Zacks Equity Research
Tilary (TLRY) acquires import and distribution partner, Alef Biotechnology to strengthen its base in Latin America.
The Zacks Analyst Blog Highlights: Tilray, Raytheon, Boyd Gaming, Altria Group and Simply Good Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Raytheon, Boyd Gaming, Altria Group and Simply Good Foods
Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Tilray, Inc. (TLRY) closed at $146.91, marking a +1.2% move from the previous day.
Get Over Marijuana, Indulge in These 4 Sin Stocks Instead
by Tirthankar Chakraborty
Products and services of sin stocks are relatively inelastic and the very nature of their business ensures a steady stream of consumers, irrespective of market conditions.
Pot Stocks & ETF: Risks and Rewards
by Neena Mishra
Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
Wall Street's Reefer Madness, Micron Earnings, & More Stock News
by Ryan McQueeney
Ryan McQueeney and Maddy Johnson discuss the performance of Netflix and other streaming services at the Emmys. The team also chat about the alleged criminal probe facing Elon Musk and Tesla. Later, they discuss marijuana stocks and recap Micron's latest earnings report.
Is Goldilocks Market Coming?
by Zacks Equity Research
Is Goldilocks Market Coming?
How Much Longer for the Goldilocks Market?
by Mark Vickery
Investors who've been around the block a few times tend to look for something around the corner that threatens to stick a pin in this ever-expanding balloon.
Zacks Investment Ideas feature highlights: Tilray, Tesla and Microsoft
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Tilray, Tesla and Microsoft
Company News For Sep 20, 2018
by Zacks Equity Research
Companies In The News are: TLRY,FB,CPRT,ABBV
Cannabis Company Tilray's (TLRY) Shares Up 856% Since July
by Zacks Equity Research
Tilray (TLRY) inks an import deal with the U.S. Drug Enforcement Administration for a trial on neurological movement disorder.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Zacks Investment Ideas feature highlights: Tilray
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Tilray
What's Happening to Option Prices During the Tilray Short Squeeze?
by David Borun
A tiny public float and a short squeeze result in very strange-looking options prices
Tesla Bull Sells (and Buys Again?) & Dow Rallies Near Highs | Free Lunch
by Ryan McQueeney
Ryan McQueeney highlights the Dow's rally toward all-time highs on the back of strength from financial stocks. He also touches on news related to marijuana producers and reported activist interest in casino giant MGM. Later, the host calls Brian Bolan, a noted Tesla bull, to discuss a major shift in his sentiment for the electric car company.
Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports
by Ryan McQueeney
Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.
Tilray Rallies Again: Anatomy of a Short Squeeze
by David Borun
Adding 50% to yesterday's rally, Tilray has one of the wildest rides in recent memory
Why Marijuana Stocks and ETF are Soaring
by Neena Mishra
Pot stocks are hot but also very volatile, here is what investors need to know
Will Disruptive Technology Play a Role in the Marijuana Industry?
by Ryan McQueeney
Ryan McQueeney discusses the intersection of disruptive technology and the budding marijuana industry, ultimately concluding that investors should remember what they've learned about investing in other forms of new tech as it becomes a bigger factor in the cannabis business.